Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Eur Rev Med Pharmacol Sci. 2021 Jan;25(1):301-312. doi: 10.26355/eurrev_202101_24396.
Coronary artery disease (CAD) is the main cause of mortality worldwide. How stable coronary artery disease (SCAD) progresses to acute myocardial infarction (AMI) is not known. This study was aimed to explore the differentially expressed genes (DEGs) and pathways involved in the progression of SCAD to AMI.
Publicly available gene-expression profiles (GSE71226, GSE97320, GSE66360) were downloaded from the Gene Expression Omnibus (GEO) database and integrated to identify DEGs. The GSE59867 dataset was further used to verify the result of screened DEGs. Functional-enrichment analyses, protein-protein interaction network, microRNA-transcription factor (TF)-mRNA regulatory network, and drug-gene network were visualized.
Sixty common DEGs (CDEGs) were screened between the SCAD-Control group and AMI-Control group in the integrated dataset. Four upregulated DEGs were selected from GSE59867. Twenty hub genes were discovered, and three significant modules were constructed in the PPI network. The intersection of functional and pathway-enrichment analyses of 60 CDEGs and the module DEGs indicated that they were mainly involved in "inflammatory response", "immune response", and "cytokine-cytokine receptor interaction". A miRNA-TF-mRNA regulatory network comprised 87 miRNAs, 16 upregulated target DEGs and 7 TFs.
We identified several important genes and miRNAs involved in the progression of SCAD to AMI: platelet activating factor receptor (PTAFR), aquaoporin-9 (AQP9), toll-like receptor-4 (TLR4), human constitutive androstane receptor-3 (HCAR3), leucine-rich-α2 glycoprotein-1 (LRG1), mothers Against Decapentaplegic Homolog 4 (SMAD4) and miRNA-149-5p, miRNA-6778-3p, and miRNA-520a-3p. Inflammation and the immune response had important roles in the progression from SCAD to AMI.
冠心病(CAD)是全球主要的死亡原因。尚不清楚稳定性冠心病(SCAD)如何发展为急性心肌梗死(AMI)。本研究旨在探讨SCAD 进展为 AMI 过程中涉及的差异表达基因(DEGs)和途径。
从基因表达综合数据库(GEO)下载公开的基因表达谱(GSE71226、GSE97320、GSE66360),并进行整合以鉴定 DEGs。进一步使用 GSE59867 数据集验证筛选出的 DEGs 的结果。可视化功能富集分析、蛋白质-蛋白质相互作用网络、miRNA-转录因子(TF)-mRNA 调控网络和药物-基因网络。
在整合数据集的 SCAD-对照和 AMI-对照组之间筛选出 60 个共同的 DEGs(CDEGs)。从 GSE59867 中选择了 4 个上调的 DEGs。发现了 20 个枢纽基因,并构建了 PPI 网络中的 3 个显著模块。对 60 个 CDEGs 和模块 DEGs 的功能和途径富集分析的交集表明,它们主要涉及“炎症反应”、“免疫反应”和“细胞因子-细胞因子受体相互作用”。miRNA-TF-mRNA 调控网络包含 87 个 miRNA、16 个上调的靶标 DEGs 和 7 个 TF。
我们鉴定了几个参与 SCAD 进展为 AMI 的重要基因和 miRNA:血小板激活因子受体(PTAFR)、水通道蛋白-9(AQP9)、 toll 样受体-4(TLR4)、人组成型和甾醇受体 3(HCAR3)、富含亮氨酸的α2 糖蛋白-1(LRG1)、母亲抗 Decapentaplegic 同源物 4(SMAD4)和 miRNA-149-5p、miRNA-6778-3p 和 miRNA-520a-3p。炎症和免疫反应在 SCAD 向 AMI 的进展中起着重要作用。